EUVIMEDEUVIMED entdecken
Crossref

Integrating 16S rRNA profiling and in-silico analysis for an epitope-based vaccine strategy against Achromobacter xylosoxidans infection

Muhammad Naveed, Ali Hassan, Tariq Aziz, Urooj Ali, Ayaz Ali Khan, Metab Alharbi, Abdulrahman Alshammari

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Muhammad Naveed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, Pakistan. Electronic address: naveed.quaidian@g…. Hauptthemen laut MEDLINE: Achromobacter denitrificans, Bacterial Vaccines, RNA, Ribosomal, 16S, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Achromobacter xylosoxidans is an aerobic, catalase-positive, non-pigment-forming, Gram-negative, and motile bacterium. It potentially causes a wide range of human infections in cystic fibrosis and non-cystic fibrosis patients. However, developing a safe preventive or therapeutic solution against A. xylosoxidans remains challenging. This study aimed to construct an epitope-based vaccine candidate using immunoinformatic techniques. A. xylosoxidans was isolated from an auto workshop in Lahore, and its identification was confirmed through 16S rRNA amplification and bioinformatic analysis. Two protein targets with GenBank accession numbers AKP90890.1 and AKP90355.1 were selected for the vaccine construct. Both proteins exhibited antigenicity, with scores of 0.757 and 0.580, respectively and the epitopes were selected based on the IC50 value using the ANN 4.0 and NN-align 2.3 epitope prediction method for MHC I and MHC II epitopes respectively and predicted epitopes were analyzed for antigenicity, allergenicity and pathogenicity. The vaccine construct demonstrated structural stability, thermostability, solubility, and hydrophilicity. The vaccine produced 250 B-memory cells per mm3 and approximately 16,000 IgM + IgG counts, indicating an effective immune response against A. xylosoxidans. Moreover, the vaccine candidate interacted stably with toll-like receptor 5, a pattern recognition receptor, with a confidence score of 0.98. These results highlight the potency of the designed vaccine candidate, suggesting its potential to withstand rigorous in vitro and in vivo clinical trials. This epitope-based vaccine could serve as the first preventive immunotherapy against A. xylosoxidans infections, addressing this bacterium's health and financial burdens. The findings demonstrate the value of employing immunoinformatic tools in vaccine development, paving the way for more precise and tailored approaches to combating microbial threats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Achromobacter denitrificansBacterial VaccinesRNA, Ribosomal, 16SGram-Negative Bacterial InfectionsHumansAnimalsEpitopesComputer SimulationFemaleAntibodies, BacterialMiceComputational BiologyAntigens, Bacterial

Stichwörter der Autor:innen

16S rRNA sequencingAchromobacter xylosoxidansIdentificationImmunoinformaticsImmunotherapyReverse vaccinology

Substanzen

Bacterial VaccinesRNA, Ribosomal, 16SEpitopesAntibodies, BacterialAntigens, Bacterial

Autor:innen und Institutionen

  • Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, Pakistan. Electronic address: naveed.quaidian@gmail.com.
  • Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, Pakistan.
  • Department of Agriculture University of Ioannina Arta 47100 Greece. Electronic address: iwockd@gmail.com.
  • Department of Biotechnology, Quaid-I-Azam University, Islamabad Pakistan.
  • Department of Biotechnology, University of Malakand Chakdara Dir Lower 18800 Pakistan.
  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.

Förderung

  • King Saud University

Zitieren

APA

Naveed, M., Hassan, A., Aziz, T., Ali, U., Khan, A. A., Alharbi, M., & Alshammari, A. (2024). Integrating 16S rRNA profiling and in-silico analysis for an epitope-based vaccine strategy against Achromobacter xylosoxidans infection. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112287

Vancouver

Naveed M, Hassan A, Aziz T, Ali U, Khan AA, Alharbi M, et al. Integrating 16S rRNA profiling and in-silico analysis for an epitope-based vaccine strategy against Achromobacter xylosoxidans infection. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112287

BibTeX
@article{Naveed2024,
  author = {Naveed, Muhammad and Hassan, Ali and Aziz, Tariq and Ali, Urooj and Khan, Ayaz Ali and Alharbi, Metab and Alshammari, Abdulrahman},
  title = {Integrating 16S rRNA profiling and in-silico analysis for an epitope-based vaccine strategy against Achromobacter xylosoxidans infection},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112287}
}
Kostenlos starten →